PRESS RELEASE published on 01/24/2024 at 09:02, 2 years 2 months ago Original-Research: VOQUZ Labs AG (von NuWays AG): BUY VOQUZ Labs AG has been upgraded from NuWays AG with a recommendation to buy. The company recently published strong 2023 order intake figures, indicating improved operations in the second half of the year. With a reassuring order intake and strong trading momentum, the company is expected to see sequential improvements in 2023 and return to double-digit top-line growth, positive EBITDA, and FCF generation in 2024. The compelling mid-term prospects and undemanding valuation indicate favorable investment potential. EBITDA VOQUZ Labs AG NuWays AG 2023 Order Intake Mid-term Prospects
Published on 04/09/2026 at 19:15, 1 hour 23 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 38 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 58 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 38 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 7 hours 8 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:15, 2 hours 23 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 4 hours 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 18:35, 2 hours 3 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 4 hours 40 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 38 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago Publication of the 2025 Universal Registration Document